LensGen® is a clinical stage company based in Irvine, California developing Juvene™, the first modular, fluid-optic intraocular lens (IOL) designed to treat cataracts and presbyopia.
Juvene was developed using biomimetic design principals to closely mimic the shape and function of the natural crystalline lens. Juvene is a modular IOL with a base lens and a curvature-changing fluid lens that fits through a small incision and fills the entire volume of the capsule.
Juvene offers the potential promise to address common sides effects with current presbyopia correction IOLs and bring us closer to the ideal IOL by meeting the following requirements:
Dr. Sumit Garg, MD, Medical Director, Gavin Herbert Eye Institute, University California Irvine, will present for the first time in Europe the early results of the Grail clinical study.
LensGen is seeking to close its Series B Financing by the end of 2019.
→ Click here to visit the LensGen website